Gelteq Limited (NASDAQ: GELS) and Healthy Extracts Inc. (OTCQB: HYEX) have entered into a Memorandum of Understanding that will bring Gelteq’s proprietary gel‑delivery technology into U.S. manufacturing and global distribution. Under the agreement, Healthy Extracts will use its in‑house production facilities to manufacture new gel‑based nutraceutical products under Gelteq’s formulations, technical processes and expertise, while retaining full ownership of Gelteq’s intellectual property.
The partnership designates Healthy Extracts as the primary manufacturer, commercial seller and distributor for the new product line, with the option to white‑label finished goods for select customers. Gelteq will provide the technical transfer required for U.S. production and will collaborate on marketing and future product development. The MoU is intended to accelerate commercial rollout, strengthen supply‑chain reliability and meet growing global demand for science‑backed delivery formats.
Strategically, the deal positions Gelteq to capture a larger share of the nutraceutical sector by leveraging Healthy Extracts’ manufacturing capacity and distribution network. The partnership creates a new revenue stream for Gelteq and enables rapid scale‑up in the U.S., while also opening pathways into emerging markets such as China. The MoU builds on existing relationships, including prior purchases of Gelteq‑formulated products by Healthy Extracts and a 50% increase in its initial order in December 2024.
"This partnership marks a significant step in expanding the reach of our gel‑based technologies," said Nathan Givoni, CEO of Gelteq. "Healthy Extracts brings the manufacturing strength and market presence needed to introduce new gel‑format nutraceuticals at scale. We’re thrilled to see our technology applied to new product categories and new global markets." Don Swanson, CEO of Healthy Extracts, added, "The agreement expands our product pipeline with next‑generation gel‑based nutraceuticals and establishes a clear pathway to scalable U.S. manufacturing and commercial execution."
The announcement was met with a positive market reaction, with the stock rising 7.4% following the news. Investors viewed the partnership as a catalyst for Gelteq’s growth and commercialization efforts in the U.S., anticipating increased revenue streams and enhanced market share.
The collaboration also strengthens supply‑chain resilience and positions both companies to capitalize on the growing demand for gel‑based delivery formats. By combining Gelteq’s technology with Healthy Extracts’ manufacturing and distribution capabilities, the partnership is expected to accelerate product development, reduce time‑to‑market, and create new opportunities for joint innovation in the nutraceutical space.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.